17-17794090-C-T
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_030665.4(RAI1):c.1142C>T(p.Ala381Val) variant causes a missense change. The variant allele was found at a frequency of 0.00445 in 1,614,076 control chromosomes in the GnomAD database, including 30 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A381G) has been classified as Uncertain significance.
Frequency
Consequence
NM_030665.4 missense
Scores
Clinical Significance
Conservation
Publications
- Smith-Magenis syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), G2P
- Potocki-Lupski syndromeInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.00400  AC: 609AN: 152206Hom.:  2  Cov.: 33 show subpopulations 
GnomAD2 exomes  AF:  0.00382  AC: 959AN: 251210 AF XY:  0.00378   show subpopulations 
GnomAD4 exome  AF:  0.00449  AC: 6569AN: 1461752Hom.:  28  Cov.: 95 AF XY:  0.00447  AC XY: 3253AN XY: 727170 show subpopulations 
Age Distribution
GnomAD4 genome  0.00400  AC: 609AN: 152324Hom.:  2  Cov.: 33 AF XY:  0.00388  AC XY: 289AN XY: 74480 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
not specified    Benign:7 
- -
- -
- -
- -
- -
- -
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
not provided    Benign:3 
- -
- -
RAI1: BP4, BS2 -
Inborn genetic diseases    Benign:1 
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Smith-Magenis syndrome    Benign:1 
- -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at